Is HBA1C reliable in diagnosing diabetes in the acute phase of acute coronary syndromes?
نویسندگان
چکیده
Abstract Funding Acknowledgements Type of funding sources: None. Introduction Hospitalization due to acute coronary syndromes (ACS) usually is the occasion that leads diagnosis type 2 diabetes mellitus (T2DM). Current literature suggests severity ACS could be associated with presence and DM. Purpose To study reliability HbA1c in T2DM phase ACS, as well possible correlation between ACS. Methods We evaluated 160 consecutive patients admitted was measured on day 1 90. >6.5% used diagnose 5.7-6.4% pre-diabetes. The assessed via Gensini score. Results are interpreted mean ± SD. Comparisons were made by one way ANOVA(p < 0.05 regarded statistically significant).Spearman’s rank score other parameters. Mean age 59.73 12.21 years. 103/160(64.37%) male 57/160(35.63%) female. 19/160(11.87%) diagnosed STEMI 141/160(88.13%) NSTEMI. BMI 29.55 8.41 kg/m2 Hb 12.62 2.08 g/dl. On 1, 43/160 (26.87%) had > 6.5% 41/160(25.62%) 5.7-6.4%. 90, 28/160 (17.5%) 52/160(32.5%) varied 0-144 value 40.26 ±35.9. A strong found admission 90 (rho-0.36, p rho = 0.32, respectively). Conclusion seems reliable identification pre-diabetes but not relate worst prognosis patients.
منابع مشابه
Prognostic value of C-Reactive Protein in Acute Coronary Syndromes
Introduction: Coronary artery disease (CAD) is among the most common, serious, chronic and life- threatening illnesses in the world. CAD represents a spectrum of conditions, with acute myocardial infarction at one end of it and silent ischemia at the other. There is growing evidence on importance of prognosis of C- reactive protein (CPR) in unstable angina and this protein is a maker of an adve...
متن کاملcost benefits of rehabilitation after acute coronary syndrome in iran; using an epidemiological model
چکیده ندارد.
Statins in acute coronary syndromes.
Statins are the main resource available to reduce LDL-cholesterol levels. Their continuous use decreases cardiovascular morbidity and mortality due to atherosclerosis. The administration of these medications demonstrated to be effective in primary and secondary prevention clinical trials in low and high risk patients. Specialists believe that a possible benefit of hypolipidemic therapy in preve...
متن کاملInflammation in acute coronary syndromes.
Extensive evidence supports a pathogenic role for both local and systemic inflammation in acute coronary syndromes. However, several important questions remain unanswered. Is the observed inflammatory process a precursor or a consequence of coronary plaque rupture? Is the inflammatory component of unstable coronary disease a potential therapeutic target? Finally, do infectious agents have a pat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European heart journal. Acute cardiovascular care
سال: 2021
ISSN: ['2048-8726', '2048-8734']
DOI: https://doi.org/10.1093/ehjacc/zuab020.104